Valuation: Biogen Inc.

Market Cap 30.72B 26.58B 24.82B 22.77B 42.82B 2,924B 43.5B 291B 114B 1,466B 115B 113B 4,845B P/E 2026 *
37.8x
P/E 2027 * 18.3x
Enterprise Value 35.81B 30.97B 28.92B 26.53B 49.9B 3,408B 50.7B 339B 133B 1,708B 134B 132B 5,647B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.13x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day+0.80%
1 week+2.46%
Current month+2.46%
1 month+1.09%
3 months+8.65%
6 months+3.36%
Current year+18.15%
1 week 199.58
Extreme 199.58
212.18
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 127.71
Extreme 127.71
219.72
3 years 110.04
Extreme 110.035
276.52
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%+2.46%+62.77%-23.33% 30.72B
+1.59%+2.85%+40.11%+1.24% 78.32B
-0.84%+0.09%+20.92%+179.15% 49.18B
+2.77%+4.78%-1.65%+27.62% 51.1B
-0.13%+7.42%-50.22%-49.58% 44.71B
+1.84%+0.87%+54.17%+85.73% 24.44B
+9.86%+7.94%+122.36%-41.53% 23.62B
+4.29%+9.40%+3.77%+226.51% 21.05B
+1.66%-3.70%+65.40%+123.91% 16.61B
+2.03%+5.48%+83.85%+172.87% 16.51B
Average +2.39%+4.22%+40.15%+70.26% 35.63B
Weighted average by Cap. +1.89%+4.35%+29.57%+51.03%

Financials

2026 *2027 *
Net sales 10.42B 9.01B 8.42B 7.72B 14.53B 992B 14.76B 98.77B 38.77B 497B 39.14B 38.28B 1,644B 10.62B 9.19B 8.58B 7.87B 14.81B 1,011B 15.04B 101B 39.52B 507B 39.9B 39.03B 1,676B
Net income 953M 824M 770M 706M 1.33B 90.71B 1.35B 9.03B 3.55B 45.46B 3.58B 3.5B 150B 1.9B 1.64B 1.53B 1.41B 2.65B 181B 2.69B 18B 7.06B 90.6B 7.13B 6.98B 300B
Net Debt 5.08B 4.4B 4.1B 3.77B 7.08B 484B 7.19B 48.16B 18.9B 242B 19.08B 18.66B 801B 2.57B 2.22B 2.07B 1.9B 3.58B 244B 3.63B 24.32B 9.55B 122B 9.64B 9.43B 405B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
07/08/26 US$207.94 +0.80% 840,505
06/08/26 US$206.28 -0.17% 892,772
05/08/26 US$206.63 -0.87% 873,781
04/08/26 US$208.45 +3.29% 1,205,704
03/08/26 US$201.82 -0.56% 940,993
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
207.94USD
Average target price
235.32USD
Spread / Average Target
+13.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock